ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Clifton F. Mountain
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mountain, C. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mountain, C. F.

Ann Thorac Surg 1977;24:365-373
© 1977 The Society of Thoracic Surgeons

Articles

Assessment of the Role of Surgery for Control of Lung Cancer

Clifton F. Mountain, M.D.

Section of Thoracic Surgery, University of Texas System Cancer Center, M. D. Anderson Hospital and Tumor Institute, 6723 Bertner, Houston, TX 77030.

When morphologically stratified, the classification of patients according to surgical stage provides an objective basis for evaluating the results of surgical treatment. In a review of 794 patients according to surgical staging criteria, the data supported concepts regarding differences in the behavior of each cell type as well as major differences in survival between each stage of disease. The overall cumulative five-year survival was 37% for squamous cell carcinoma, 27% for adenocarcinoma, and 27% for undifferentiated large cell carcinoma. Fewer than 1% of patients with undifferentiated small cell carcinoma survived. Survival for patients with surgical Stage I disease was 53%, for Stage II 29%, and for Stage III 16%.

The results of surgical treatment for patients with limited disease extent are much better than is generally realized. Fifty to 60% of such patients in this series survived five years. Survival studies by surgical stage permit reasonable estimates of the presence of occult metastatic disease and supply insights necessary to the design and appropriate selection of adjunctive therapeutic programs.




This article has been cited by other articles:


Home page
 Ann. Thorac. Surg.Home page
L. J. Daniels, S. S. Balderson, M. W. Onaitis, and T. A. D'Amico
Thoracoscopic lobectomy: a safe and effective strategy for patients with stage i lung cancer
Ann. Thorac. Surg., September 1, 2002; 74(3): 860 - 864.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
J. H. Park, Y. M. Shim, H. J. Baek, M.-S. Kim, D. H. Choe, K.-J. Cho, C.-T. Lee, and J. I. Zo
Postoperative adjuvant therapy for stage II non-small-cell lung cancer
Ann. Thorac. Surg., November 1, 1999; 68(5): 1821 - 1826.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
R. J. McKenna Jr, R. K. Wolf, M. Brenner, R. J. Fischel, and P. Wurnig
Is lobectomy by video-assisted thoracic surgery an adequate cancer operation?
Ann. Thorac. Surg., December 1, 1998; 66(6): 1903 - 1907.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
T. Tatsumura
Preoperative and intraoperative ultrasonographic examination as an aid in lung cancer operations
J. Thorac. Cardiovasc. Surg., September 1, 1995; 110(3): 606 - 612.
[Abstract] [Full Text]

Home page
 Ann. Thorac. Surg.Home page
P. Icard, J.-F. Regnard, A. Essomba, V. Panebianco, P. Magdeleinat, and P. Levasseur
Preoperative carcinoembryonic antigen level as a prognostic indicator in resected primary lung cancer
Ann. Thorac. Surg., September 1, 1994; 58(3): 811 - 814.
[Abstract] [PDF]

Home page
 Ann. Thorac. Surg.Home page
P. Icard, J.-F. Regnard, S. de Napoli, A. Rojas-Miranda, P. Dartevelle, and P. Levasseur
Primary lung cancer in young patients: A study of 82 surgically treated patients
Ann. Thorac. Surg., July 1, 1992; 54(1): 99 - 103.
[Abstract] [PDF]

Home page
 Ann. Thorac. Surg.Home page
R. S. Downey, C. W. Sewell, and K. A. Mansour
Large cell carcinoma of the lung: A highly aggressive tumor with dismal prognosis
Ann. Thorac. Surg., June 1, 1989; 47(6): 806 - 808.
[Abstract] [PDF]

Home page
 Ann. Thorac. Surg.Home page
H. Nakahashi, K. Yasumoto, T. Ishida, A. Nagashima, T. Nishino, T. Oka, and K. Sugimachi
Results of Surgical Treatment of Patients with T3 Non--Small Cell Lung Cancer
Ann. Thorac. Surg., August 1, 1988; 46(2): 178 - 181.
[Abstract] [PDF]

Home page
 Ann. Thorac. Surg.Home page
E. C. Holmes
Carcinoma of the Lung
Ann. Thorac. Surg., May 1, 1988; 45(5): 582 - 582.
[PDF]

Home page
 Ann. Thorac. Surg.Home page
J. Deslauriers
Role of Mediastinoscopy in Lung Cancer: Reply
Ann. Thorac. Surg., November 1, 1986; 42(5): 601 - 601.
[PDF]

Home page
 Ann. Thorac. Surg.Home page
C. F. Mountain
The Biological Operability of Stage III Non-Small Cell Lung Cancer
Ann. Thorac. Surg., July 1, 1985; 40(1): 60 - 64.
[Abstract] [PDF]

Home page
 Ann. Thorac. Surg.Home page
J. H. Pemberton, D. M. Nagorney, J. C. Gilmore, W. F. Taylor, and P. E. Bernatz
Bronchogenic Carcinoma in Patients Younger than 40 Years
Ann. Thorac. Surg., November 1, 1983; 36(5): 509 - 515.
[Abstract] [PDF]

Home page
 Ann. Thorac. Surg.Home page
Thoracic Surgery Quiz: Answers
Ann. Thorac. Surg., April 1, 1982; 33(4): 417 - 417.
[PDF]

Home page
 Ann. Thorac. Surg.Home page
W. F. Bennett and R. A. Smith
Segmental Resection for Bronchogenic Carcinoma: A Surgical Alternative for the Compromised Patient
Ann. Thorac. Surg., February 1, 1979; 27(2): 169 - 172.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1977 by The Society of Thoracic Surgeons.